Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) operates in the Financial Services sector, specifically the Shell Companies industry, with a market capitalization near $357.4M, listed on NASDAQ, employing roughly 2 people, carrying a beta of -0.00 to the broader market. Drugs Made In America Acquisition Corp. Led by Roger Bendelac, public since 2025-01-27.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for DMAA as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →